SCHEMBL3501420

SCHEMBL3501420

CCCCO[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O

nearest known ligand 0.56

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.49
GBA1 P04062 5/20 0.49
MAPK1 P28482 1/20 0.46
LGALS8 O00214 1/20 0.42
LGALS3 P17931 1/20 0.42
LGALS4 P56470 1/20 0.42
GJB2 P29033 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950601 1.00 SLC2A1 (0.49) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL8435866 1.00 SLC2A1 (0.49) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL9652492 1.00 SLC2A1 (0.49) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL21518296 1.00 SLC2A1 (0.49) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL16395631 0.95 GBA1 (0.56) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL3502893 0.95 GBA1 (0.56) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL7696481 0.95 GBA1 (0.56) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL10388278 0.95 SLC2A1 (0.54) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL11222662 0.95 SLC2A1 (0.54) SLC2A1GBA1MAPK1LGALS8LGALS3
SCHEMBL16678877 0.95 SLC2A1 (0.54) SLC2A1GBA1MAPK1LGALS8LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110315930-A1 Compositions and methods for analyzing biomolecules using mass spectroscopy Life Technologies Corporation (US) 2011-12-29 US claimed
US-20100187475-A1 Compositions and Methods for Analyzing Biomolecules Using Mass Spectroscopy Life Technologies Corporation (US) 2010-07-29 US claimed
WO-2006047614-A2 COMPOSITIONS AND METHODS FOR ANALYZING BIOMOLECULES USING MASS SPECTROSCOPY INVITROGEN CORPORATION (US) 2006-05-04 WO claimed
US-20110315930-A1 Compositions and methods for analyzing biomolecules using mass spectroscopy Life Technologies Corporation (US) 2011-12-29 US disclosed
US-20100187475-A1 Compositions and Methods for Analyzing Biomolecules Using Mass Spectroscopy Life Technologies Corporation (US) 2010-07-29 US disclosed
US-20060214104-A1 Compositions and methods for analyzing biomolecules using mass spectroscopy INVITROGEN CORPORATION (US) 2006-09-28 US disclosed
WO-2006047614-A2 COMPOSITIONS AND METHODS FOR ANALYZING BIOMOLECULES USING MASS SPECTROSCOPY INVITROGEN CORPORATION (US) 2006-05-04 WO disclosed
EP-0394280-B1 ESTERS OF GLYCOSIDES AND A PROCESS FOR ENZYMATIC PREPARATION THEREOF NOVO NORDISK AS (DK) 1995-04-05 EP disclosed
EP-0239900-B1 PROCESS FOR PRODUCING COLOUR-STABLE INDUSTRIAL-GRADE METHYL GLUCOSIDE CPC INTERNATIONAL INC. (US) 1992-11-19 EP disclosed
EP-0394280-A1 ESTERS OF GLYCOSIDES AND A PROCESS FOR ENZYMATIC PREPARATION THEREOF. NOVO NORDISK AS (DK) 1990-10-31 EP disclosed
WO-1989001480-A1 ESTERS OF GLYCOSIDES AND A PROCESS FOR ENZYMATIC PREPARATION THEREOF NOVO-NORDISK A/S (DK) 1989-02-23 WO disclosed
US-4797478-A Process for producing color-stable, industrial-grade methyl glucoside CPC INTERNATIONAL INC. (US) 1989-01-10 US disclosed
EP-0239900-A2 Process for producing colour-stable industrial-grade methyl glucoside CPC INTERNATIONAL INC. (US) 1987-10-07 EP disclosed